TABLE 2.
First author | Type of study | Location | Tools | Sample size | Prevalence of PPD (%) |
---|---|---|---|---|---|
An 18 | Cross‐sectional | China | EPDS ≥10 | 209 | 56.9 |
Ceulemans 19 |
Cross‐sectional | Ireland, Norway, Switzerland, Netherlands, United Kingdom | EPDS ≥13 | 5134 | 13 |
Stojanov 20 | Cross‐sectional | Serbia | EPDS ≥10 | 108 | 14.8 |
Fallon 21 | Cross‐sectional | UK | EPDS ≥13 | 614 | 43 |
Guvenc 22 | Cross‐sectional | Turkey | EPDS ≥13 | 212 | 34.0 |
Hiiragi 23 | Retrospective cohort | Japan | EPDS ≥9 | 279 | 14 |
Baran 11 | Cross‐sectional | Poland | EPDS ≥11 | 130 | 40 |
Liang 24 | Cross‐sectional | China | EPDS ≥10 | 864 | 30.0 |
Loret de Mola 25 | Retrospective cohort | Brazil | EPDS ≥13 | 1042 | 29.3 |
Mariño‐Narvaez 26 | Cross‐sectional | Spanish | EPDS ≥10 | 75 | 22.4 |
Oskovi‐Kaplan 27 | Cross‐sectional | Turkey | EPDS ≥13 | 223 | 14.7 |
Ostacoli 28 | Cross‐sectional | Italy | EPDS ≥11 | 163 | 44.2 |
Pariente 29 | Retrospective cohort | Israel | EPDS ≥10 | 223 | 16.7 |
Spinola 30 | Cross‐sectional | Italy | EPDS ≥12 | 243 | 44 |
Suárez‐Rico 31 | Cross‐sectional | Mexico | EPDS ≥13 | 293 | 39.2 |
Suzuki 32 | Cross‐sectional | Japan | EPDS ≥9 | 132 | 14.4 |
Myers 33 | Cross‐sectional | United Kingdom | EPDS ≥11 | 162 | 47.5 |
Vatcheva 34 | Cross‐sectional | Belgium | EPDS ≥13 | 34 | 26 |
Hui 35 | Retrospective cohort | Hong Kong | EPDS ≥10 | 802 | 2.9 |
Hui 35 | Retrospective cohort | Hong Kong | EPDS ≥10 | 925 | 14.4 |
Miranda 4 | Cross‐sectional | Argentina | PDSS‐SF ≥17 | 305 | 37 |
Terada 36 | Cross‐sectional | Japan | EPDS ≥9 | 461 | 7.6 |
Zanardo 13 | Case – control | Italy | EPDS ≥12 | 91 | 26 |
Tarabay 37 | Cross‐sectional | Saudi Arabia | EPDS ≥10 | 150 | 60.7 |
Madera 38 | Case – control | Italy | EPDS ≥12 | 295 | 11.9 |
Abbreviations: EPDS, Edinburgh Postnatal Depression Scal; PDSS‐SF, Postpartum Depression Screening Scale‐Short Form; PPD, postpartum depression.
Bold values indicate statistically significant.